Medica 2026
Nov 16-19, 2026 - Düsseldorf, Germany
ADLM 2026
July 26-30, 2026 – Anaheim, CA, USA

Enterohemorrhagic E. coli (EHEC)

Introduction to Enterohemorrhagic E. coli (EHEC)

Escherichia coli is a gram-negative, rod-shaped bacterium commonly found in the human colon. While most E. coli strains are harmless and part of the normal gut flora, some strains, particularly those causing gastrointestinal diseases, fall into the category of diarrheagenic E. coli. These include Shiga toxin-producing E. coli (STEC) and enterohemorrhagic E. coli (EHEC). Among these, E. coli O157:H7 is the most prominent EHEC strain, known for its extremely low infectious dose, estimated at only 10 to 100 cells. EHEC strains produce Shiga toxin, which can cause severe gastrointestinal symptoms and are linked to life-threatening conditions such as hemolytic uremic syndrome (HUS), a condition characterized by kidney failure, anemia, and low platelet counts.

Mechanism of EHEC Infection

The main virulence factor which makes HUS-inducing EHEC strains different from others is their ability to produce Shiga toxin. The two Shiga toxin variants exist as Stx1 and Stx2 where Stx2a and Stx2c subtypes show the strongest connection to HUS development. The AB5 toxin family includes Shiga toxins which bind to human cell glycosphingolipids such as globotriaosylceramide (Gb3) that exist on endothelial cells of glomeruli and brain tissue. The toxins block protein translation in host cells which results in cell death. The blood vessel damage and blood clot formation during HUS development occur because of these factors.

The consumption of EHEC-contaminated food items including undercooked meat and vegetables and fruits leads to bacterial colonization of the gut by the bacteria which then produces Shiga toxins. The bacterial genome of EHEC contains a prophage which functions as a viral DNA sequence integrated into its genetic material. The prophage exists in a dormant state during the lysogenic phase but becomes active when the bacterium faces environmental stressors such as antibiotic exposure which triggers the lytic cycle and Shiga toxin production. The toxins enter host cells through endocytosis after which they cause severe gastrointestinal symptoms including abdominal pain and bloody diarrhea.

Mechanism of enterohemorrhagic Escherichia coli (EHEC) infection and Shiga toxin production. (Strzelecki, 2025)Figure 1. Mechanism of enterohemorrhagic Escherichia coli (EHEC) infection and Shiga toxin production. (Strzelecki, 2025)

EHEC and the Microbiome

The pathogenic process of EHEC involves complex interactions between the bacteria and the microbial community of the host. Studies using gnotobiotic animals demonstrate that the intestinal microbiota functions as a protective mechanism which stops harmful pathogens from colonizing the gut. EHEC has developed particular signals which it uses to control its virulence factors through the help of specific gut bacterial signals. The activation of the Shiga-toxin encoding phage occurs when certain commensal bacteria are present in the gut. Research shows that the microbiome plays a role in controlling Shiga-toxin-related diseases including HUS. The ratio between beneficial microbiota and pathogenic EHEC determines the severity of infection because microbial imbalances (dysbiosis) create conditions for pathogen colonization and toxin production.

Native species of the gut microbiome interact with EHEC by outcompeting the pathogen for crucial nutrients. (Perraud, 2025)Figure 2. Native species of the gut microbiome interact with EHEC by outcompeting the pathogen for crucial nutrients. (Perraud, 2025)

EHEC Laboratory Testing Methods

Cultural Techniques

  • Sorbitol MacConkey Agar (sMac) detects E. coli O157 through its inability to ferment sorbitol but shows poor detection rates at 50-60%.
  • The selective broth enrichment method helps to improve the recovery of E. coli O157.

Immunoassays

  • The serotype-specific enzyme immunoassays show high sensitivity levels between 73-100% but they only detect E. coli O157.
  • PCR Assays detect Shiga toxins and virulence factors with high sensitivity but these tests are not commonly used in laboratories.
  • The cytotoxin testing method needs specialized tissue culture facilities yet it operates outside standard laboratory protocols.

EHEC continues to be a dangerous pathogen which causes severe health problems including bloody diarrhea and HUS. The management and prevention of EHEC infections require prompt detection through molecular and cultural and immunological testing methods. The development of CRISPR-Cas12/13 and microfluidic chip technologies will lead to faster and more accurate EHEC diagnostic methods that enhance medical results and public health reaction capabilities.

References

  1. Nguyen, Y., and Vanessa Sperandio. "Enterohemorrhagic E. coli (EHEC) pathogenesis."Frontiers in cellular and infection microbiology 2 (2012): 90.
  2. Strzelecki, Patryk, et al. "Phytochemicals Controlling Enterohemorrhagic Escherichia coli (EHEC) Virulence—Current Knowledge of Their Mechanisms of Action."International Journal of Molecular Sciences 26.1 (2025): 381.
  3. Perraud, Quentin, and Vanessa Sperandio. "Enterohemorrhagic E. coli (EHEC) and the microbiome."PLoS pathogens 21.6 (2025): e1013224.

EHEC Antigens

TargetCat. No.Product NameHost
E. coliDAG-ZL0479Inactivated Escherichia coli EHEC O157:H7 Culture FluidN/AInquiry

E.coli Verotoxin/Shiga Toxin Antibodies

TargetCat. No.Product NameHostIsotypeApplication
E. coli VerotoxinDMAB-CS24972HiResNb™ Alpaca Anti-E. coli Stx2B Monoclonal Antibody, clone A5289AlpacaVHHELISA, SPRInquiry
DMAB-CAB5119Human Anti-E. coli stx1B Monoclonal antibody, clone 1204HumanIgG1, kappaELISA, NeutInquiry
DMAB-CAB5120Human Anti-E. coli stx2A Monoclonal antibody, clone 22F21HumanIgG1, kappaELISA, NeutInquiry
DMAB-CAB5121Human Anti-E. coli stx2B Monoclonal antibody, clone 1205HumanIgG1, kappaELISA, NeutInquiry
DMABT-Z60597Anti-Verotoxin 2 beta monoclonal antibody, clone 369MouseIgGELISAInquiry
DMABT-Z60598Anti-Verotoxin II / SLT 2a monoclonal antibody, clone 569MouseIgG1ELISAInquiry
DMAB4507Anti-Verotoxin I B subunit monoclonal antibody, clone A358MouseIgG1ELISA, NeutInquiry
DMAB4509Anti-Verotoxin II A subunit monoclonal antibody, clone A558MouseIgG2ELISA, NeutInquiry
DMAB4510Anti-Verotoxin II B subunit monoclonal antibody, clone A258MouseIgGELISA, NeutInquiry
DMABT-51263MEAnti-E. coli Verotoxin (SLT-2a) Monoclonal antibody, Clone 8696MouseIgG2ELISAInquiry
DCABY-821Anti-E. coli type 1b Verotoxin Monoclonal antibody, Clone 8694MouseIgG1ELISAInquiry
DCABY-822Anti-E. coli type 2b Verotoxin Monoclonal antibody, Clone 8693MouseIgGELISAInquiry
DCABY-823Anti-E. coli type 2a Verotoxin Monoclonal antibody, Clone 8695MouseIgG1ELISAInquiry
CABT-L7850Mouse anti Shiga toxin type I monoclonal antibody, clone Mab53MouseIgGELISA (Cap)Inquiry
CABT-L7851Mouse anti Shiga toxin type I monoclonal antibody, clone Mab54MouseIgGELISA (Det)Inquiry
CABT-L7852Mouse anti Shiga toxin type II monoclonal antibody, clone Mab55MouseIgGELISA (Cap)Inquiry
CABT-L7853Mouse anti Shiga toxin type II monoclonal antibody, clone Mab56MouseIgGELISA (Det)Inquiry
CABT-CS105Mouse Anti-Vero Toxin/Shiga Toxin subunit A Monoclonal antibody, clone WF12MouseIgG1WB, ELISA, ICInquiry
CABT-B1083Anti-Shiga Toxin 2 polyclonal antibodyRabbitIgGWB, sELISAInquiry
DMAB-CS23149Mouse Anti-Shiga Toxin type I-B Monoclonal antibody, clone SH02MouseIgG1ELISAInquiry
DMAB-CS23150Mouse Anti-Shiga Toxin type II-A Monoclonal antibody, clone SH03MouseIgG2ELISAInquiry
DMAB-CS23151Mouse Anti-Shiga Toxin type II-B Monoclonal antibody, clone SH04MouseIgG2bELISAInquiry
CABT-ZB644Mouse Anti-E.coli Shiga toxin II subunit B monoclonal antibody, clone NN19MouseIgGELISA (cap)Inquiry
CABT-ZB988Mouse Anti-E.coli Shiga toxin II subunit B monoclonal antibody, clone NN24MouseIgGELISA, ELISA (det)Inquiry
CABT-B1080Anti-Shiga Like Toxin 1 monoclonal antibody, clone WU115MouseIgG1, &kappaWB, ELISAInquiry
CABT-B1081Anti-Shiga Like Toxin 2 monoclonal antibody, clone WO467MouseIgG1, &kappaELISAInquiry
CABT-B8719Anti-E. coli STX 1 & 2 monoclonal antibodyMouseIgGELISA, WB, NeutInquiry
CABT-CS104Rabbit Anti-Vero Toxin (E.coli) / Shiga Toxin (S. dysenteriae) Polyclonal antibodyRabbitIgGWB, Dot, IPInquiry
ABPR-ZB223E.coli Shiga toxin II subunit B Antibody Pair SetMouseIgGsELISAInquiry
DCABH-21Anti-E. coli Toxin A Monoclonal antibodyMouseIgG1WB, ELISAInquiry

E.coli Verotoxin/Shiga Toxin Antigens

E.coli Verotoxin/Shiga Toxin ELISA Kits

TargetCat. No.Product NameSizeSpeciesApplicationDetection Sample
E. coli VerotoxinDEIA2348E. Coli Verotoxin (Fecal) ELISA Kit96THumanQualitativeStool supernatantInquiry
DEIA1966E. Coli Verotoxin 1+2 Ag ELISA Kit96TQualitativeStool specimens, broth culturesInquiry
DEIASL162Shiga toxins ELISA Kit96THumanQualitativeFecalInquiry
Inquiry Basket